Stay updated on IDara in Elderly MM Clinical Trial
Sign up to get notified when there's something new on the IDara in Elderly MM Clinical Trial page.

Latest updates to the IDara in Elderly MM Clinical Trial page
- Check4 days agoChange DetectedNew metadata and keywords were added to the study record, including ixazomib, daratumumab, Multiple Myeloma, and University Hospital Caen, along with data-sharing terms. These updates align the record with indexing standards and improve its discoverability and contextual understanding.SummaryDifference45%

- Check11 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the page with likely behind-the-scenes updates rather than user-facing content.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page no longer shows the 'Multiple myeloma' topic tag and the related topics block. This removal also takes out the MedlinePlus Genetics link from the related topics, reducing quick access to related resources.SummaryDifference0.2%

- Check26 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 on the page. This indicates a minor internal update to the page content, with no changes to study data or eligibility details.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded related-topic links for Multiple myeloma and MedlinePlus Genetics under the Resources section to provide quick access to background information.SummaryDifference0.2%

- Check40 days agoChange DetectedA new citation for a dexamethasone-free daratumumab-ixazomib regimen study in frail elderly patients with relapsed/refractory multiple myeloma was added to Publications, and the previous 'Online ahead of print' note for that citation was removed.SummaryDifference0.1%

Stay in the know with updates to IDara in Elderly MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDara in Elderly MM Clinical Trial page.